HUVEC/TERT662024-05-16T08:36:56+00:00

Umbilical cord

HUVEC/TERT66

Evercyte’s human umbilical vein endothelial cell line HUVEC/TERT66 is grown continuously under xeno-free conditions while maintaining expression of cell type specific markers and functions. Therefore, these cells can be used to study vascularization in response to hypoxic conditions in tumors or ischemic tissues, to assess interaction of endothelial cells with leukocytes, macrophages or mesenchymal stem cells and to perform toxicity studies as well as to test novel compounds for pro- or anti-angiogenic activities.

from

€ 1600,–

HUVEC/TERT66
Cat#: CHT-006-0066

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Products

umbilical vein endothelial cells

HUVEC/TERT2

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Good cell culture practice / GCCP

get ready to standardize your cell culture work

news

Lecture on 3Rs

(replacement – reduction -refinement of animal experiments)

services

substance testing

Extracellular vesicles and angiogenesis

bioassay to test the neo-angiogenic potential of extracellular vesicles

Related Products

human umbilical vein endothelial cells HUVEC/TERT2

Related Services

testing pro- and anti-angiogenic properties of novel drugs

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

from

€ 1300,–

HUVEC/TERT66
Cat#: CHT-006-0066

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Go to Top